Home
Statistics
How It Works
Login
Register
Keyword Connections
-
lung adenocarcinoma
Keywords
Connection Type
Connection
Journals
pediatrics
Nucleic Acids Research
the clinical respiratory journal
OncoTargets and therapy
clinical cancer research : an official journal of the american association for cancer research
lung cancer (amsterdam, netherlands)
Journal of cellular and molecular medicine
Disease models & mechanisms
journal of thoracic oncology : official publication of the international association for the study of lung cancer
ebiomedicine
biochimica et biophysica acta molecular cell research
acta virologica
Cornea
journal of the american society of cytopathology
Research Groups
No Research Group Connected
Bibliographies
[1]
Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations.
[2]
Counting of viable C. burnetii cells by quantitative reverse transcription PCR using a recombinant plasmid (pCB-dotA) as a standard.
[3]
Use of a Purpose-Built Impression Cytology Device for Gene Expression Quantification at the Ocular Surface Using Quantitative PCR and Droplet Digital PCR.
[4]
ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network.
[5]
Claudin-2 binding peptides, VPDSM and DSMKF, down-regulate claudin-2 expression and anticancer resistance in human lung adenocarcinoma A549 cells.
[6]
Prognostic significance of preoperative consolidation to maximum tumour diameter ratio and SUVmax in pathological stage I lung adenocarcinoma.
[7]
FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway.
[8]
Gefitinib and afatinib show potential efficacy for Fanconi anemia-related head and neck cancer.
[9]
Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
[10]
Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma.
[11]
expression of opn3 in lung adenocarcinoma promotes epithelial‐mesenchymal transition and tumor metastasis
[12]
the predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas
[13]
radiotherapy for a phalanx bone metastasis of a lung adenocarcinoma
[14]
association between cd47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
[15]
morphological features of choroidal metastases: an oct analysis
[16]
icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
[17]
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
[18]
Elevated murine HB-EGF confers sensitivity to diphtheria toxin in EGFR-mutant lung adenocarcinoma.
[19]
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
[20]
Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma
[21]
Hypomethylation-activated cancer-testis gene SPANXC promotes cell metastasis in lung adenocarcinoma.
[22]
Novel Carbazole-Piperazine Hybrid Small Molecule Induces Apoptosis by Targeting BCL-2 and Inhibits Tumor Progression in Lung Adenocarcinoma in Vitro and Xenograft Mice Model.
[23]
Osteopontin drives KRAS-mutant lung adenocarcinoma.
[24]
ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network.
[25]
Claudin-2 binding peptides, VPDSM and DSMKF, down-regulate claudin-2 expression and anticancer resistance in human lung adenocarcinoma A549 cells.
[26]
Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma
[27]
The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
[28]
Prognostic significance of preoperative consolidation to maximum tumour diameter ratio and SUVmax in pathological stage I lung adenocarcinoma.
[29]
Leptomeningeal metastases of lung adenocarcinoma detected by 18F-FDG PET/CT.
[30]
FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway.
[31]
Corrigendum to: SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21 , cyclin D1 and β-catenin.
[32]
Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma.
[33]
Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
[34]
Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
[35]
Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
[36]
Semiautomated Laser Capture Microdissection of Lung Adenocarcinoma Cytology Samples
[37]
Low Galectin-3 Expression Level in Primary Tumors Is Associated with Metastasis in T1 Lung Adenocarcinoma
[38]
Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma.
[39]
expression of opn3 in lung adenocarcinoma promotes epithelial‐mesenchymal transition and tumor metastasis
[40]
the predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas
[41]
microrna expression profiles predict progression and clinical outcome in lung adenocarcinoma
[42]
radiotherapy for a phalanx bone metastasis of a lung adenocarcinoma
[43]
gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
[44]
nivolumab-induced autoimmune encephalitis in two patients with lung adenocarcinoma
[45]
role of the expression level of nrf2 in predicting response of egfr-tkis in lung adenocarcinoma patients with egfr gene mutations
[46]
anticancer effects of sinulariolide-conjugated hyaluronan nanoparticles on lung adenocarcinoma cells
[47]
lung adenocarcinomas and lung cancer cell lines show association of mmp-1 expression with stat3 activation
[48]
identification of minimal p53 promoter region regulated by malat1 in human lung adenocarcinoma cells
[49]
epidermal growth factor receptor mutations and their prognostic value with carcinoembryonic antigen in pathological t1 lung adenocarcinoma
[50]
therapeutic potential of andrographolide isolated from the leaves of andrographis paniculata nees for treating lung adenocarcinomas
[51]
deep sequence analysis of non-small cell lung cancer: integrated analysis of gene expression, alternative splicing, and single nucleotide variations in lung adenocarcinomas with and without oncogenic kras mutations
[52]
resveratrol inhibits egf-induced invasion of human lung adenocarcinoma a549 cells
[53]
levels of pedf in pleural effusions from lung adenocarcinoma and benign disease patients
[54]
icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
[55]
expression of dll4 and vegf in lung adenocarcinoma and their relationship with angiogenesis in tumor
[56]
combining carcinoembryonic antigen and platelet to lymphocyte ratio to predict brain metastasis of resected lung adenocarcinoma patients
[57]
propensity score matching analysis of vats lobectomy and sublobar resection for stage i lung adenocarcinoma
[58]
a preliminary study on the origin of human lung adenocarcinoma stem cells from lung bonchioalveolar stem cells
[59]
aquaporin 1 is an independent marker of poor prognosis in lung adenocarcinoma
[60]
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
[61]
Elevated murine HB-EGF confers sensitivity to diphtheria toxin in EGFR-mutant lung adenocarcinoma.
[62]
Ectopic Expression of TIGIT in Lung Adenocarcinoma and Its Clinical Significance.
[63]
A comprehensive study on thiadiazole-based anticancer agents inducing cell cycle arrest and apoptosis/necrosis through suppression of akt activity in lung adenocarcinoma and glioma cells
[64]
Effect of Flammulina velutipes polysaccharide on mitochondrial apoptosis in lung adenocarcinoma A549 cells